Video
Gender disparity seen with renal cell carcinoma management
Author(s):
Meredith R. Metcalf, MD, discusses recent research evaluating management of clinical T1a RCC in men and women.
In this interview, Meredith R. Metcalf, MD, discusses a paper published in Urology titled "Gender Differences in the Clinical Management of Renal Cell Carcinoma," for which she served as a study author. Metcalf is instructor of urology at Johns Hopkins University, Baltimore.
More videos:
Prolapse surgery outcomes compared in nursing home residents, community-dwelling adults
Effect of an online opioid training course on prescription patterns for urologic surgeries
Sperm parameters maintained in most men taking nasal testosterone gel
Related Videos
Study findings highlight gender gaps in oncology authorship and citation
Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
Study data point to gender disparities in oncology research citations
Nitin Yerram, MD, highlights new resource center for patients with renal cell carcinoma
Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Darren Feldman, MD, on study of 177Lu-girentuximab plus nivolumab for ccRCC
Francesca Jackson-Spence, MBChB, details the ongoing SAMETA trial in papillary renal cancer
Kate Gessner, MD, on systemic agents vs MDT after kidney cancer progression
Taylor Goodstein, MD, highlights project on staging in larger kidney tumors
Chad Tang, MD: Considerations for SBRT in metastatic RCC
Related Content
